Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atopic dermatitis
Pharma
Ivonescimab, Fosun-Sitala, Hutchmed—Fierce Pharma Asia
Akeso and Summit's ivonescimab bagged its first overall survival win. Fosun inked another licensing deal. Hutchmed's CEO took medical leave. And more.
Angus Liu
Aug 29, 2025 8:15am
Leo increases sales in US and bumps up 2025 revenue guidance
Aug 19, 2025 12:38pm
FDA signs off on Leo Pharma's chronic hand eczema cream Anzupgo
Jul 24, 2025 8:45am
Galderma starts DTC campaign for eczema drug across TV, digital
Apr 22, 2025 10:55am
Leo survey shows chronic hand eczema’s effects on patient lives
Apr 22, 2025 6:00am
Leo Pharma finds derms want better chronic hand eczema meds
Mar 5, 2025 1:07pm
